Adalimumab-adbm injection is a citrate-free formulation and is supplied as 40mg/0.8mL, 20mg/0.4mL and 10mg/0.2mL prefilled syringes and as a 40mg/0.8mL prefilled autoinjector.

Biologic medication for ulcerative colitis may work better for you if other treatments don’t. Learn 10 important facts about ...

Adalimumab injection was approved by FDA for the treatment of psoriasis (including pediatric plaque psoriasis), and is widely used in the North America and Europe for this disease.

Adalimumab injection was approved by FDA for the treatment of psoriasis (including pediatric plaque psoriasis), and is widely used in the North America and Europe for this disease.

SULINNO®, a adalimumab biosimilar has similar clinical efficacy and safety to adalimumab, and its clinical results were published in the Inaugural Issue of The Lancet Rheumatology in 2019.

SIMLANDI is approved by the U.S. Food and Drug Administration (FDA) as the first high-concentration, citrate-free biosimilar to Humira with interchangeability exclusivity for the 40mg/0.4mL injection.

Patients receiving intranodular injections of adalimumab (Humira) showed significant declines in nodule hardness and volume over 18 months, whereas these remained stable or increased in a saline ...

The launch of SULINNO ® has provided more Chinese patients with high-quality and relatively affordable adalimumab injection, bringing hope and opportunities to more patients.